-
16065-5A fluorinated analog of AEA that serves as a substrate of FAAH (Km = 29 µM) used to perform n-FABS against FAAH to identify novel inhibitors.
-
16065-500A fluorinated analog of AEA that serves as a substrate of FAAH (Km = 29 µM) used to perform n-FABS against FAAH to identify novel inhibitors.
-
17119-1A benzoxazolone carboxamide that potently inhibits acid ceramidase (IC<sub>50</sub> = 79 nM) extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice, significantly reducing
-
17119-10A benzoxazolone carboxamide that potently inhibits acid ceramidase (IC<sub>50</sub> = 79 nM) extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice, significantly reducing
-
17119-25A benzoxazolone carboxamide that potently inhibits acid ceramidase (IC<sub>50</sub> = 79 nM) extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice, significantly reducing
-
17119-5A benzoxazolone carboxamide that potently inhibits acid ceramidase (IC<sub>50</sub> = 79 nM) extremely stable in buffers and plasma and shows good pharmacokinetics when administered intravenously or intraperitoneally in mice, significantly reducing
-
A5032-500 mg
Thomas Scientific
Aromatase inhibitor that prevents adrenal steroid synthesis. It is used to treat breast cancer and Cushing’s disease. (C08-0488-805)
Price: $238.92List Price: $265.46D,L-Aminogluthethimide is an inhibitor of aromatase and adrenal steroid synthesis that exhibits immunosuppressive and anticancer chemotherapeutic activities. This compound is used to treat breast cancer and Cushing’s disease. -
A5032-1 g
Thomas Scientific
Aromatase inhibitor that prevents adrenal steroid synthesis. It is used to treat breast cancer and Cushing’s disease. (C08-0489-114)
Price: $341.47List Price: $379.41D,L-Aminogluthethimide is an inhibitor of aromatase and adrenal steroid synthesis that exhibits immunosuppressive and anticancer chemotherapeutic activities. This compound is used to treat breast cancer and Cushing’s disease. -
A5302-100 mg
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-034)
Price: $302.20List Price: $335.78Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
A5302-250 mg
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-396)
Price: $518.80List Price: $576.44Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
A5302-1 g
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-826)
Price: $1,576.80List Price: $1,752.00Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
13321-1A selective inhibitor of matrix metalloproteinase-2 (MMP-2) demonstrating an IC50 value of 12 nM significantly less potent towards MMP-1, MMP-3, MMP-7, and MMP-9 (IC<sub>50</sub> = 50, 4.5, 50, and 2 µM, respectively) suppresses invasive